Product Program year 2025 Source: CMS Open Payments

Akreos AO IOL

Device Ophthalmology

PDI 10757770481368

Open in the dashboard

General payments

$584,587

1,936 payments

Research payments

$0

0 payments

Through program year 2025, $584,587 in general payments and $0 in research payments were reported against Akreos AO IOL (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $144 3
2024 General $261 6
2023 General $96,557 272
2022 General $305,544 881
2021 General $182,081 774

Breakdown

Who paid General payments · program years 2021–2025
  1. Bausch & Lomb Americas Inc. $402,479 1,161 payments
  2. Bausch & Lomb, a division of Bausch Health US, LLC $182,081 774 payments
  3. Salix Pharmaceuticals, a division of Bausch Health US, LLC $26 1 payment
Top recipients General payments · program year 2025
  1. Forrest Swann Cornea and External Diseases Specialist · Waco, TX $101 70% · 1 payment
  2. Monique Barbour Ophthalmology · Lake Worth Fl, FL $27 19% · 1 payment
  3. Sunali Goyal Ophthalmology · Orlando, FL $15 11% · 1 payment

Each share is of general payments naming this product in 2025.

Specialties paid General payments · program year 2025
  1. Cornea and External Diseases Specialist Ophthalmology $101 70% · 1 practitioner
  2. Ophthalmology $43 30% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Texas $101 70% · 1 recipient
  2. Florida $43 30% · 2 recipients

Each share is of general payments naming this product in 2025 where a state was reported.

1,936 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record